2023
ClickArr: a novel, high-throughput assay for evaluating beta-arrestin isoform recruitment.
French AR*, Meqbil Y, and van Rijn RM*.
Frontiers in Pharmacology, 14.
Modified akuamma alkaloids with increased potency at the mu opioid receptor.
Hennessy MR, Gutridge AM, French AR, Rhoda ES, Gill M, Kashyap Y, Wang ZJ, van Rijn RM, and Riley AP*.
Journal of Medicinal Chemistry, 66(5), 3312–3326.
LILAC: enhanced actin imaging with an optogenetic Lifeact.
Kroll KL, French AR, Sosnick TR*, and Rock RS*.
Nature Methods, 20, 214–217.
2022
Sex- and β-arrestin-dependent effects of kappa opioid receptor-mediated ethanol consumption.
French AR*, Gutridge AM, Yuan J, Royer QH, and van Rijn RM.
Pharmacology, Biochemistry and Behavior, 216(173377).
French AR and van Rijn RM*.
Pharmacological Research, 117.
2021
Evaluation of kratom opioid derivatives as potential treatment options for alcohol use disorder.
Gutridge AM, Chakraborty S, Varga BR, Rhoda ES, French AR, Blaine AT, Royer QH, Cui H, Yuan J, Cassell RJ, Szabó M, Majumdar S*, and van Rijn RM*.
Frontiers in Pharmacology, 12, 2943-2960.
2019
Dual-mode FRET and BRET sensors for detecting cAMP dynamics.
French AR, Tesmer AL, and Tantama M*.
ACS Omega, 4(13), 15504-15511.
Ratiometric BRET measurements of ATP with a genetically encoded luminescent sensor.
Min S-H, French AR, Trull KJ, Tat K, Varney SA, and Tantama M*.
Sensors, 19(16), 3502.
2017
Investigations of human myosin VI targeting using optogenetically controlled cargo loading.
French AR, Sosnick TR*, and Rock RS*.
Proc Natl Acad Sci USA, 114(9), E1607-E1616.
2013
Zayner JP, Antoniou C, French AR, Hause RJ Jr, and Sosnick TR*.
Biophysical Journal, 105(4), 1027–1036.
2010
Wood MD, MacEwan MR, French AR, Moore AM, Hunter DA, Mackinnon SE, Moran DW, Borschel GH, and Sakiyama-Elbert SE*.
Biotechnology and Bioengineering, 106(6), 970–979.
*corresponding or co-corresponding author
Click here for a complete list of French lab publications.